Blood Cancers

Cancers of the blood (hematologic malignancies) affect the bone marrow, blood cells, lymph nodes and other parts of the lymphatic system. Malignancies in the blood interfere with normal blood cell production or function. As the cancer cells multiply, they stop your blood from performing essential functions such as fighting off infection.

Decades of scientific research and clinical trials have led to more effective treatments and better outcomes for the more than 150,000 people diagnosed with blood cancers each year.

At the University of Chicago Medicine, we’re at the forefront of leading-edge research, the latest clinical trials and the newest treatments for leukemia, lymphoma and multiple myeloma.

Our patients have access to advanced treatments not available at most medical centers, such as stem cell transplantation and CAR T-cell therapy, a treatment that supercharges a patient's T cells to recognize and destroy cancer cells. Many patients receive stem cell transplants or CAR T-cell therapy on an outpatient basis, enabling them to return to the comfort of their home or nearby accommodations between treatments and appointments, rather than staying in the hospital. 

Offering the Most Advanced Care for Blood Cancers

Leukemia

We care for more than 300 patients with leukemia, myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN) each year, making our program one of the largest in Chicago.

Lymphoma (Hodgkin and Non-Hodgkin)

We are at the forefront of developing new therapies for Hodgkin and non-Hodgkin lymphomas, bringing the newest treatments to our patients as soon as they are available.

Multiple Myeloma

New medications, targeted therapies and cellular therapies have changed the landscape for patients with multiple myeloma. UChicago Medicine offers all of the latest treatments for this complex condition.